San
Francisco, 05 April, Stem Cells Market Analysis By Product
(Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application
(Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment
Forecasts, 2018 - 2025
The global stem cell market is expected to reach USD 15.63billion
by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View
Research, Inc. Augmentation in research studies that aim at broadening the
utility scope of associated products is anticipated to drive the market growth.
These research projects have opened the possibility of implementation of
several clinical applications of these cells, thereby impacting
disease-modifying treatments.
Scientists
are engaged in discovering novel methods to create human stem cells. This is to
address the increasing demand for stem cell production for potential
investigation in disease management. This factor is certainly expected to
accelerate the development of regenerative medicine, thus driving industrial
growth.
Moreover,
cellular therapies are recognized as the next major advancements in
transforming healthcare. Firms are expanding their cellular therapy portfolio,
understanding the future potential of this arena in the treatment of
Parkinson's disease, type 1 diabetes, spinal cord injury, Alzheimer's disease,
and others.
In
March 2016, Scientists at Michigan State University unveiled new kind of cells
“induced XEN cells” from a cellular trash pile. This discovery is expected to
drive advancements in regenerative medicine. Such discoveries are anticipated
to bolster research and sales in this market over the forecast period.
Access Full
Research Report On Stem Cells Market Analysis:
Further key findings from the report
suggest:
·
Adult stem cells dominated the
market and is expected to maintain its dominance. This can be attributed to the
several factors such as lower rejection rates, long term renewal property, and
no ethical concerns associated with their usage
·
Application wise regenerative
medicine is estimated to hold the substantial share of the revenue
·
Presence of significant number
pipeline projects for regenerative medicine is expected to fuel growth in the
market
·
In addition, exploding research
projects have driven the need of harvesting techniques, thereby propelling
progress of acquisition technology
·
Increased R&D activities
and huge funds granted by funding bodies to advance cellular research in the
U.S. have resulted into the large share of North America
·
Extensive research carried out
in Singapore and Japan is anticipated to drive progress with lucrative avenues
·
Advanced Cell Technology Inc,
Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and
STEMCELL Technologies Inc., are some of the major companies operating in this
market
·
A number of companies are
engaged in seeking investment from overseas organizations and also developing
partnerships with the pharmaceutical organizations
Browse More Reports Of This
Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the global stem cells market on the basis of product, application,
technology, therapy, and region:
Stem
Cell Product Outlook (Revenue, USD Billion, 2014 - 2025)
·
Adult Stem Cells
o
Neuronal Stem Cells
o
Hematopoietic Stem Cells
o
Mesenchymal Stem Cells
o
Umbilical Cord Stem Cells
o
Others
·
Human Embryonic Stem Cells
·
Induced Pluripotent Stem Cells
·
Very Small Embryonic Like Stem
Cells
Stem
Cell Application Outlook (Revenue, USD Billion, 2014 - 2025)
·
Regenerative Medicine
o
Neurology
o
Orthopedics
o
Oncology
o
Hematology
o
Cardiovascular and Myocardial
Infraction
o
Injuries
o
Diabetes
o
Liver Disorder
o
Incontinence
o
Others
·
Drug Discovery and Development
Stem
Cell Technology Outlook (Revenue, USD Billion, 2014 - 2025)
·
Cell Acquisition
o
Bone Marrow Harvest
o
Umbilical Blood Cord
o
Apheresis
·
Cell Production
o
Therapeutic Cloning
o
In-vitro Fertilization
o
Cell Culture
o
Isolation
·
Cryopreservation
·
Expansion and Sub-Culture
Stem
Cell Therapy Outlook (Revenue, USD Billion, 2014 - 2025)
·
Autologous Stem Cell Therapy
·
Allogeneic Stem Cell Therapy
Stem
Cell Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
Middle East & Africa
o
South Africa
Access Full
Press Release of this Report: https://www.grandviewresearch.com/press-release/global-stem-cells-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more
information: www.grandviewresearch.com/
No comments:
Post a Comment